Sterile Processing

Latest News



Seqirus announced today that the US Food and Drug Administration (FDA) has approved Fluad Quadrivalent, touted as the first and only adjuvanted quadrivalent influenza vaccine, developed to help protect adults 65 years and older against seasonal influenza.

Outbreaks in NICUs are particularly challenging in that not only are the patients vulnerable to infections, but often the design and layout of these units (often a pin-wheel configuration) coupled with family visits bring about inherent challenges.